If society is to derive the maximum benefit from personalized medicine – which will require companies to pursue it – regulators worldwide will need to adopt reasoned and reasonable policies.
如果社会要从个性化用药中获得最大利益——这要求制药公司也主动这样做——那么全世界的监管者就应该采取可靠合理的政策。